Molecular dissection of mouse soluble guanylyl cyclase α1 promoter

被引:13
|
作者
Vazquez-Padron, RI [1 ]
Pham, SM
Pang, MH
Li, S
Aïtouche, A
机构
[1] Miami Univ, Dept Surg, Miami, FL USA
[2] Miami Univ, Vasc Biol Inst, Miami, FL USA
关键词
soluble guanylyl cyclase; promoter; dinucleotide microsatellites; transcriptional regulation; UTR regions;
D O I
10.1016/j.bbrc.2003.12.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble guanylyl cyclase (sGC) is the only known receptor for nitric oxide (NO) and is downregulated in aging and hypertension. Little is known about sGC gene transcriptional regulation. In order to characterize the sGC transcriptional system, we cloned and sequenced the 5' flanking region of mouse sGC a(1) gene (AY116663). Structurally, it is a non-canonical TATA-less promoter that we mapped to chromosome 3 with many putative regulation sites for Sp-1, NF-kappaB, and AP-1 transcription factors amongst others, and two (TG:CA)(n) dinucleotide microsatellites near the transcriptional start point. The cloned upstream sequence produced a 5-fold increase in luciferase activity in Cos7, HeLa, NIH3T3, and 293 cells as well as in mouse VSMC-like kidney mesangial cells. In the latter cell type, we showed that sGC alpha(1) promoter activity was dependent on the presence of its 5' unstranslated region (5'UTR). (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 50 条
  • [41] Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats
    Ruetten, H
    Zabel, U
    Linz, W
    Schmidt, HHHW
    CIRCULATION RESEARCH, 1999, 85 (06) : 534 - 541
  • [42] Heterogeneous expression of NO-activated soluble guanylyl cyclase in mammalian heart
    Brahmajothi, Mulugu V.
    Campbell, Donald L.
    CHANNELS, 2007, 1 (05) : 353 - 365
  • [43] Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells
    Bellamy, TC
    Garthwaite, J
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (01) : 95 - 103
  • [44] Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase
    Rekowski, Margarete von Wantoch
    Pyriochou, Anastasia
    Papapetropoulos, Nektarios
    Stoessel, Anne
    Papapetropoulos, Andreas
    Giannis, Athanassios
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (03) : 1288 - 1296
  • [45] Inhibition of soluble guanylyl cyclase by small molecules targeting the catalytic domain
    Vijayaraghavan, Jagamya
    Kramp, Kristopher
    Harris, Michael E.
    van den Akker, Focco
    FEBS LETTERS, 2016, 590 (20) : 3669 - 3680
  • [46] Soluble guanylyl cyclase is localized at the neuromuscular junction in human skeletal muscle
    Schoser, BGH
    Behrends, S
    NEUROREPORT, 2001, 12 (05) : 979 - 981
  • [48] Regulation and immunhistochemical localization of nitric oxide synthases and soluble guanylyl cyclase in mouse spinal cord following nociceptive stimulation
    Maihöfner, C
    Euchenhofer, C
    Tegeder, I
    Beck, KF
    Pfeilschifter, J
    Geisslinger, G
    NEUROSCIENCE LETTERS, 2000, 290 (01) : 71 - 75
  • [49] Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation
    Hoffmann, L. S.
    Schmidt, P. M.
    Keim, Y.
    Schaefer, S.
    Schmidt, H. H. H. W.
    Stasch, J. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (05) : 781 - 795
  • [50] Dental Pulp Inflammation Initiates the Occurrence of Mast Cells Expressing the α1 and β1 Subunits of Soluble Guanylyl Cyclase
    Korkmaz, Yueksel
    Plomann, Markus
    Puladi, Behrus
    Demirbas, Ayseguel
    Bloch, Wilhelm
    Deschner, James
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)